journal article·2011-06-28

Aspect Ratio Determines the Quantity of Mesoporous Silica Nanoparticle Uptake by a Small GTPase-Dependent Macropinocytosis Mechanism

Huan Meng, Sui Yang, Zongxi Li, Tian Xia, Justin Chen, Zhaoxia Ji, Haiyuan Zhang, Xiang Wang, Sijie Lin, Connie Huang, Z. Hong Zhou, Jeffrey I. Zink, Andre E. Nel

ACS Nano· Volume 5· Issue 6
Publisher page

Abstract

Although the aspect ratio (AR) of engineered nanomaterials (ENMs) is one of the key physicochemical parameters that could determine biological outcome, not much is understood about how AR contributes to shaping biological outcome. By using a mesoporous silica nanoparticle (MSNP) library that has been constructed to cover a range of different lengths, we could demonstrate that the AR of rod-shaped particles determines the rate and abundance of MSNP uptake by a macropinocytosis process in HeLa and A549 cancer cell lines. MSNPs with an AR of 2.1-2.5 were taken up in larger quantities compared to shorter or longer length rods by a process that is sensitive to amiloride, cytochalasin D, azide, and 4 °C inhibition. The rods with intermediary AR also induced the maximal number of filopodia, actin polymerization, and activation of small GTP-binding proteins (e.g., Rac1, CDC42) that involve assembly of the actin cytoskeleton and filopodia formation. When assessing the role of AR in the delivery of paclitaxel or camptothecin, the rods with AR 2.1-2.5 were clearly more efficient for drug delivery and generation of cytotoxic killing in HeLa cells. All considered, our data suggest an active sensoring mechanism by which HeLa and A549 cells are capable of detecting AR differences in MSNP to the extent that accelerated macropinocytosis can be used to achieve more efficient drug delivery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Diatoms and Algae Research · Cellular Mechanics and Interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of NanoMedicine, Department of Medicine, ‡Department of Chemistry & Biochemistry, §Department of Microbiology, Immunology, and Molecular Genetics, and ⊥California NanoSystems Institute, University of California, Los Angeles, California 90095, United States

References (71)

Show source-provided references
1. Gratton S. E. A. · Proc. Natl. Acad. Sci. U.S.A. · 2008 · 105 · 1161310.1073/pnas.0801763105 ↗
2. Decuzzi P. · J. Controlled Release · 2010 · 141 · 32010.1016/j.jconrel.2009.10.014 ↗
3. Mitragotri S. · Nat. Mater. · 2009 · 8 · 1510.1038/nmat2344 ↗
4. Chithrani B. D. · Nano Lett. · 2006 · 6 · 66210.1021/nl052396o ↗
5. Yang S. · Angew. Chem., Int. Ed. · 2007 · 46 · 857910.1002/anie.200703628 ↗
6. Doshi N. · PLoS ONE · 2010 · 5 · e1005110.1371/journal.pone.0010051 ↗
7. Lee S.-Y. · Nanotechnology · 2009 · 20 · 49510110.1088/0957-4484/20/49/495101 ↗
8. Champion J. A. · J. Controlled Release · 2007 · 121 · 310.1016/j.jconrel.2007.03.022 ↗
9. Meng H. · ACS Nano · 2009 · 3 · 162010.1021/nn9005973 ↗
10. Nel A. E. · Nat. Mater. · 2009 · 8 · 54310.1038/nmat2442 ↗
11. Lu J. · Small · 2007 · 3 · 134110.1002/smll.200700005 ↗
12. Meng H. · ACS Nano · 2010 · 4 · 453910.1021/nn100690m ↗
13. Xia T. · ACS Nano · 2009 · 3 · 327310.1021/nn900918w ↗
14. Liong M. · ACS Nano · 2008 · 2 · 88910.1021/nn800072t ↗
15. Meng H. · J. Am. Chem. Soc. · 2010 · 132 · 1269010.1021/ja104501a ↗
16. Liong M. · J. Mater. Chem. · 2009 · 19 · 625110.1039/b902462j ↗
17. Ferris D. P. · J. Am. Chem. Soc. · 2009 · 131 · 168610.1021/ja807798g ↗
18. Coti K. K. · Nanoscale · 2009 · 1 · 1610.1039/b9nr00162j ↗
19. Yang S. · J. Am. Chem. Soc. · 2006 · 128 · 1046010.1021/ja0619049 ↗
20. Kresge C. T. · Nature · 1992 · 359 · 71010.1038/359710a0 ↗
21. Zhang L. · Nanotechnology · 2008 · 19 · 43560810.1088/0957-4484/19/43/435608 ↗
22. Ohsuna T. · Small · 2005 · 1 · 23310.1002/smll.200400048 ↗
23. Huang X. · Biomaterials · 2010 · 31 · 43810.1016/j.biomaterials.2009.09.060 ↗
24. Dausend J. · Macromol. Biosci. · 2008 · 8 · 113510.1002/mabi.200800123 ↗
25. Kalin S. · J. Virol. · 2010 · 84 · 533610.1128/JVI.02494-09 ↗
26. Mercer J. · Nat. Cell Biol. · 2009 · 11 · 51010.1038/ncb0509-510 ↗
27. Nakase I. · Mol. Ther. · 2004 · 10 · 101110.1016/j.ymthe.2004.08.010 ↗
28. Hillaireau H. · Cell. Mol. Life Sci. · 2009 · 66 · 287310.1007/s00018-009-0053-z ↗
29. Sheldon H. · FASEB J. · 2009 · 23 · 51310.1096/fj.07-098269 ↗
30. West M. A. · J. Cell Biol. · 1989 · 109 · 273110.1083/jcb.109.6.2731 ↗
31. Schrijvers D. M. · J. Immunol. Methods · 2004 · 287 · 10110.1016/j.jim.2004.01.013 ↗
32. Greyner H. J. · Matrix Biol. · 2010 · 29 · 50310.1016/j.matbio.2010.06.004 ↗
33. von Delwig A. · Arthritis Res. Ther. · 2006 · 8 · 110.1186/ar1964 ↗
34. Li W. · Nanotechnology · 2008 · 19 · 14510210.1088/0957-4484/19/14/145102 ↗
35. Conner S. D. · Nature · 2003 · 422 · 3710.1038/nature01451 ↗
36. Ridley A. J. · Cell · 1992 · 70 · 40110.1016/0092-8674(92)90164-8 ↗
37. Li Q. · J. Physiol. · 2003 · 550 · 43110.1113/jphysiol.2003.039073 ↗
38. Osada T. · Gut · 1999 · 45 · 50810.1136/gut.45.4.508 ↗
39. Ueda S. · Biol. Cell · 2008 · 100 · 64510.1042/BC20070160 ↗
40. Clements B. A. · Biomaterials · 2007 · 28 · 469310.1016/j.biomaterials.2007.07.023 ↗
41. Jackson A. L. · Nat. Rev. Drug Discovery · 2010 · 9 · 5710.1038/nrd3010 ↗
42. Koivusalo M. · J. Cell Biol. · 2010 · 188 · 54710.1083/jcb.200908086 ↗
43. Mercer J. · Proc. Natl. Acad. Sci. U.S.A. · 2010 · 107 · 934610.1073/pnas.1004618107 ↗
44. Slowing I. I. · J. Am. Chem. Soc. · 2007 · 129 · 884510.1021/ja0719780 ↗
45. Champion J. A. · Proc. Natl. Acad. Sci. U.S.A. · 2006 · 103 · 493010.1073/pnas.0600997103 ↗
46. Simone E. A. · Expert Opin. Drug Delivery · 2008 · 5 · 128310.1517/17425240802567846 ↗
47. Decuzzi P. · Biophys. J. · 2008 · 94 · 379010.1529/biophysj.107.120238 ↗
48. Champion J. A. · Proc. Natl. Acad. Sci. U.S.A. · 2007 · 104 · 1190110.1073/pnas.0705326104 ↗
49. Arnida · J. Appl. Toxicol. · 2010 · 30 · 21210.1002/jat.1486 ↗
50. Chithrani B. D. · Nano Lett. · 2007 · 7 · 154210.1021/nl070363y ↗
51. Muro S. · Mol. Ther. · 2008 · 16 · 145010.1038/mt.2008.127 ↗
52. Hayakawa K. · J. Cell Sci. · 2008 · 121 · 49610.1242/jcs.022053 ↗
53. Fiorentini C. · Mol. Biol. Cell · 2001 · 12 · 206110.1091/mbc.12.7.2061 ↗
54. Muro S. · J. Cell. Sci. · 2003 · 116 · 159910.1242/jcs.00367 ↗
55. Dharmawardhane S. · Mol. Biol. Cell · 2000 · 11 · 334110.1091/mbc.11.10.3341 ↗
56. Chen L.-M. · Science · 1996 · 274 · 211510.1126/science.274.5295.2115 ↗
57. Sandgren K. J. · PLoS Pathog. · 2010 · 6 · e100086610.1371/journal.ppat.1000866 ↗
58. Sahay G. · J. Controlled Release · 2010 · 145 · 18210.1016/j.jconrel.2010.01.036 ↗
59. Geiger B. · Nat. Rev. Mol. Cell Biol. · 2009 · 10 · 2110.1038/nrm2593 ↗
60. Discher D. E. · Science · 2005 · 310 · 113910.1126/science.1116995 ↗
61. Thery M. · Proc. Natl. Acad. Sci. U.S.A. · 2006 · 103 · 1977110.1073/pnas.0609267103 ↗
62. Butler B. · Curr. Biol. · 2006 · 16 · 24210.1016/j.cub.2005.12.033 ↗
63. Roiter Y. · Nano Lett. · 2008 · 8 · 94110.1021/nl080080l ↗
64. Slowing I. I. · Small · 2009 · 5 · 5710.1002/smll.200800926 ↗
65. Glass R. · Adv. Funct. Mater. · 2003 · 13 · 56910.1002/adfm.200304331 ↗
66. Glass R. · New J. Phys. · 2004 · 6 · 10110.1088/1367-2630/6/1/101 ↗
67. Arnold M. · ChemPhysChem · 2004 · 5 · 38310.1002/cphc.200301014 ↗
68. Cavalcanti-Adam E. A. · Biophys. J. · 2007 · 92 · 296410.1529/biophysj.106.089730 ↗
69. Karmali P. P. · Nanomedicine · 2009 · 5 · 7310.1016/j.nano.2008.07.007 ↗
70. Lobo C. · Biomed. Pharmacother. · 2007 · 61 · 53110.1016/j.biopha.2007.08.008 ↗
71. Kremer J. R. · J. Struct. Biol. · 1996 · 116 · 7110.1006/jsbi.1996.0013 ↗